Ann: Imugene Dose Escalates in Phase I Clinical Trial of VAXINIA, page-66

I used to follow all the progress of Imu and know it quite well. Now I find it all a bit of a blur. There is so much news due… always.

Anyway I believe this 3 month pipeline will be enough to push us back to 50c pretty easily. This will in turn place the ATH in our short term sights. But if we can get up to that 50c mark and stay above it, then when some big fundamental news drops like a hervax deal or vaxinia/cf33 strong efficacy signs - It’ll be primed to throw past that dollar mark and beyond with some rapidity is my thoughts.